Abstract
Clinicians and patients weigh modest benefits of the antibodies against sometimes-serious side effects.
MeSH terms
-
Alzheimer Disease* / drug therapy
-
Antibodies, Monoclonal, Humanized* / adverse effects
-
Antibodies, Monoclonal, Humanized* / therapeutic use
-
Drug Approval*
-
Humans
-
Vereinigte Staaten
-
United States Food and Drug Administration*
Substances
-
Antibodies, Monoclonal, Humanized
-
aducanumab